Atria Ventures Archives

1 minute read

ReSync Bio Launches with Funding to Accelerate Drug Discovery

Key Highlights ReSync Bio launches with backing from Caffeinated Capital, Atria Ventures, and angel investors. Platform bridges digital and…

September 30, 2024